Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1012
First IPO Date
June 16, 2022
| Name | Title | Pay | Year Born |
| Lisa Graver | Chief Executive Officer | 186,000 | 1972 |
| Vilhelm Robert Wessman | Founder & Executive Chairman | 2.89M | 1969 |
| Kathryn Gunnarsson | Senior Vice President of Global Talent & People Experience | 0 | N/A |
| Harshika Sarbajna | Senior Vice President of Commercial - North America | 0 | N/A |
| Sarah Macleod | Head of Global Communications | 0 | N/A |
| Agne Pasko | Vice President & Head of Business Development | 0 | N/A |
| Anthony Maffia | Chief Quality & Regulatory Officer | 0 | N/A |
| Linda Jonsdottir | Chief Financial Officer | 0 | 1978 |
| Balaji Venkataramanan Prasad | Chief Strategy Officer | 0 | N/A |
| Neha Patel | Chief Information Officer | 0 | N/A |
| Tanya Zharov | General Counsel | 0 | 1967 |
| Benedikt Stefansson | Vice President of Investor Relations and Global Communications | 0 | N/A |
| Joseph E. McClellan | Chief Operating Officer | 0 | 1974 |
| Trisha Durant | Senior Vice President of Global Business Development and Commercial Operation, ex-North America | 0 | N/A |
Alvotech Holdings SA is an Icelandic enterprise that, operating via its subsidiary companies, undertakes the development and fabrication of biosimilar pharmaceuticals destined for international consumption.